These tumors indicate the existence of a pre-existing anti-tumor immune response, which, in some cases, might be impeded or suppressed by immune checkpoint inhibitors (ICIs) targeting molecules such as PD-1/PD-L1. The gene discussed is PDCD1; the disease is neoplasm.